In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia

Blood

Volumn 99, Issue 10, 2002, Pages 3801-3805

  Wiemels, Joseph L ^{a,b,c,d,e,f,g}   Xiao, Zhijian ^a,b,c,d,e,f   Buffler, Patricia A ^a,b,c,d,e,f   Maia, Ana T ^a,b,c,d,e,f   Ma, Xiaomei ^a,b,c,d,e,f   Dicks, Brian M ^a,b,c,d,e,f   Smith, Martyn T ^a,b,c,d,e,f   Zhang, Luoping ^a,b,c,d,e,f   Feusner, James ^a,b,c,d,e,f   Wiencke, John ^a,b,c,d,e,f   Pritchard Jones, Kathy ^a,b,c,d,e,f   Kempski, Helena ^a,b,c,d,e,f   Greaves, Mel ^a,b,c,d,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL OAKLAND   (United States)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN AML 1; PROTEIN ETO; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; GENE SEQUENCE; GENE TRANSLOCATION; HUMAN; LEUKEMOGENESIS; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRENATAL PERIOD; PRIORITY JOURNAL; UTERUS;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA, NEOPLASM; HUMANS; INFANT, NEWBORN; LEUKEMIA, MYELOID; ONCOGENE PROTEINS, FUSION; REMISSION INDUCTION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0037092955     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3801     Document Type: Article

References (33)

1. In utero rearrangements in the trithorax-related oncogene in infant leukaemias
2. Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: In utero chromosome rearrangement of 11q23
3. Monoclonal origin of concordant T-cell malignancy in identical twins
4. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia
5. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero
6. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots
7. Prenatal origin of acute lymphoblastic leukaemia in children
8. Molecular tracking of leukemogenesis in a triplet pregnancy
9. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia
10. Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia
11. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
12. Karyotype and age in acute myeloid leukemia: Are they linked?
13. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia
14. Fusion genes in solid tumors
15. Microclustering of TEL-AML1 breakpoints in childhood acute lymphoblastic leukemia
16. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): The DNA damage-repair model of translocation
17. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining
18. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining
19. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children
20. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions
21. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion
22. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission
23. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
24. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation
25. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse
26. Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia
27. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients
28. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: Results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party
29. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission
30. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
31. Expression of AML1-ETO immortalizes myeloid progenitors and cooperates with secondary mutations to induce granulocytic sarcoma/acute myeloid leukemia
32. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations
33. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes